PDCD1 and diabetes mellitus: Arauja et al. suggest a higher risk of diabetes development in the course of anti-PD-1 treatment in individuals with genotype DR3-DQ2 and DR4-DQ8 HLA-II (DRB1*03-DQB1*02:01 and DRB1*04-DQB1*03:02) [94].